CTRI Number |
CTRI/2022/06/043056 [Registered on: 07/06/2022] Trial Registered Prospectively |
Last Modified On: |
03/06/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Dentistry |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
STUDY TO COMPARE THE CLINICAL OUTCOME OF OZONE GEL VERSUS CHLORHEXIDINE GEL IN PERIODONTITIS PATIENTS. |
Scientific Title of Study
|
Efficacy of ozone gel with chlorhexidine gel delivered locally in periodontal pockets in chronic periodontitis patients. A randomized controlled double blind clinical trial |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
DR SHIVANI SACHDEVA |
Designation |
ASSOCIATE PROFESSOR |
Affiliation |
Rural Dental College; Pravara institute of medical sciences |
Address |
Department of Periodontolgy Rural Dental College
Pravara institute of medical sciences
Loni
413736 Pravara institute of medical sciences,DU, Loni Ahmadnagar MAHARASHTRA 413736 India |
Phone |
09730548805 |
Fax |
|
Email |
dr.shivani19@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DR SHIVANI SACHDEVA |
Designation |
Associate Professor |
Affiliation |
RDC Pravara institute of medical sciences |
Address |
Department of Periodontolgy Rural Dental College
Pravara institute of medical sciences
Loni
413736 Pravara institute of medical sciences, DU, Loni Ahmadnagar MAHARASHTRA 413736 India |
Phone |
09730548805 |
Fax |
|
Email |
dr.shivani19@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Shivani Sachdeva |
Designation |
Associate Professor |
Affiliation |
RDC Pravara institute of medical sciences |
Address |
Dept of Periodontolgy
Rural Dental College
Pravara institute of medical sciences
Loni
413736 Pravara institute of medical sciences, DU, Loni Ahmadnagar MAHARASHTRA 413736 India |
Phone |
09730548805 |
Fax |
|
Email |
dr.shivani19@gmail.com |
|
Source of Monetary or Material Support
|
Rural Dental College, Pravara institute of medical sciences, Loni, all cases included from the institute. |
|
Primary Sponsor
|
Name |
SHIVANI SACHDEVA |
Address |
Department of Periodontology,
Rural Dental College, PIMS Loni – 413736, Tehsil – Rahata, Ahmednagar, Maharashtra
Associate professor
9730544805
dr.shivani19@gmail.com
|
Type of Sponsor |
Other [INDIVIDUAL] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DR SHIVANI SACHDEVA |
Rural Dental College, Pravara Institute of Medical Sciences |
Department of Periodontolgy Rural Dental College
Pravara institute of medical sciences
Loni
413736 Ahmadnagar MAHARASHTRA |
9730548805
dr.shivani19@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethical Committee Pravara institute of medical sciences (IEC-PIMS DU). Loni 413736 |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: B998||Other infectious disease, (2) ICD-10 Condition: B999||Unspecified infectious disease, |
|
Intervention / Comparator Agent
|
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
50.00 Year(s) |
Gender |
Both |
Details |
1.Systemically healthy subjects with probing pocket depth of 3-7mm
2.Patients exhibited 1-2 mm of clinical attachment loss
3.Horizontal bone loss with no furcation involvement
4.Age range of 20-50 years old of any gender.
5.Patients willing to give written and informed consent before any study specific procedure.
6.Hemodynamically stable patients
|
|
ExclusionCriteria |
Details |
1.Patients requiring periodontal flap surgery
2.Recurrent history of periodontal infections and wearing orthodontic brackets.
3.Use of antibiotics in the past 3–4 weeks
4.History of use of gel application or use of mouthwash within last month
5.Patient with acute necrotizing ulcerative gingivitis, acute herpetic gingivostomatitis, allergic gingivitis, gingivitis associated with skin diseases, gingivitis associated with endocrine-metabolic disturbances, gingivitis associated with hematologic-immunologic disturbances, gingival enlargement associated with medications, gingival tumors.
5.Active Hepatitis B virus or Hepatitis C virus, HIV/AIDS
6.Subjects who having psychiatry/physical morbidity and cannot perform proper manual brushing
7.Individuals with known systemic disease
8.Smokers
9.Pregnant, lactating women, allergic to ozone gel and the patients with history of any previous periodontal or antibiotic therapy.
Subjects having any kind of disorder that compromises the ability of subject to think rationally and/or prevent from completing the study as per protocol. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Primary
1. To assess and compare the gingival index and plaque index in Group A and Group B at baseline and 3 months.
2. To assess and compare pocket depth reduction and clinical attachment levels in ozone gel group and chlorhexidine gel group at 3 months.
3. To assess and compare the colony forming units (CFU) of E.coli in plaque samples at baseline and 3 months GROUP A and GROUP B.
|
3 MONTHS |
|
Secondary Outcome
|
Outcome |
TimePoints |
1. to compare the primary outcome in different groups for age and gender |
3 months |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
15/06/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
03/05/2022 |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
ALREADY PUBLICATIONS ARE THERE RELATED TO OUR STUDY.
AND THE RESULTS WERE POSITIVE FOR OUTCOME |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response (Others) - NIL
- What additional supporting information will be shared?
Response - Study Protocol Response - Informed Consent Form Response (Others) - NIL
- Who will be able to view these files?
Response (Others) - NIL
- For what types of analyses will this data be available?
Response (Others) - NIL
- By what mechanism will data be made available?
Response (Others) - NIL
- For how long will this data be available start date provided 15-07-2021 and end date provided 05-01-2023?
Response (Others) - NIL
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
This study is a randomized, double blind, single centre, parallel group, Phase III clinical study to evaluate treatment outcome for two groups; first is the OZONE GEL (experimental /test drug) and second is the CHLOREXIDINE GROUP (gold standard). The aim of the study is to evaluate the which has better treatment outcome in reduction of periodontal pocket depth and decreasing colony forming units in chronic periodontitis patients. The primary variables will be age, gender, probing pocket depth, gain in the attachment levels, plaque index, modified gingival index, colony forming units, recurrence and healing. |